Chronimed enters court case over Bayer's patents
This article was originally published in Clinica
Executive Summary
Diagnostics manufacturer Chronimed is going to court in the US to seek a ruling that its DiaScreen urine test strip does not infringe the patents of Bayer's diagnostic division. In a tit-for-tat retaliation, Bayer filed its own legal action, days later, claiming that Chronimed's DiaScreen does indeed infringe two patents covering Bayer's MULTISTIX line of test strips.